Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 43 | 2025 | 626 | 10.770 |
Why?
|
Inflammasomes | 13 | 2025 | 150 | 4.090 |
Why?
|
Myocytes, Cardiac | 32 | 2025 | 618 | 3.240 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 22 | 2022 | 233 | 2.980 |
Why?
|
Heart Atria | 13 | 2025 | 313 | 2.120 |
Why?
|
Calcium | 22 | 2022 | 1098 | 1.830 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 8 | 2023 | 111 | 1.700 |
Why?
|
Sarcoplasmic Reticulum | 16 | 2022 | 196 | 1.630 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 14 | 2022 | 168 | 1.600 |
Why?
|
Anti-Arrhythmia Agents | 5 | 2022 | 219 | 1.460 |
Why?
|
Arrhythmias, Cardiac | 11 | 2024 | 459 | 1.430 |
Why?
|
Calcium Signaling | 14 | 2021 | 241 | 1.420 |
Why?
|
Heart Rate | 7 | 2022 | 587 | 1.130 |
Why?
|
Tachycardia, Ventricular | 7 | 2022 | 197 | 1.070 |
Why?
|
Sinoatrial Node | 4 | 2024 | 24 | 1.050 |
Why?
|
Atrial Remodeling | 2 | 2024 | 12 | 1.040 |
Why?
|
Phosphate-Binding Proteins | 2 | 2025 | 10 | 1.030 |
Why?
|
Diet, High-Protein | 1 | 2024 | 5 | 0.910 |
Why?
|
Animals | 59 | 2025 | 33817 | 0.900 |
Why?
|
Signal Transduction | 8 | 2023 | 4495 | 0.840 |
Why?
|
Mice | 37 | 2025 | 17546 | 0.840 |
Why?
|
Sick Sinus Syndrome | 1 | 2022 | 12 | 0.840 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2025 | 555 | 0.820 |
Why?
|
Interleukin-6 | 2 | 2024 | 395 | 0.810 |
Why?
|
Myocardium | 10 | 2020 | 986 | 0.790 |
Why?
|
Heart Failure | 12 | 2024 | 2129 | 0.740 |
Why?
|
MicroRNAs | 4 | 2015 | 829 | 0.730 |
Why?
|
Tacrolimus Binding Proteins | 4 | 2016 | 66 | 0.730 |
Why?
|
Berberine | 3 | 2010 | 10 | 0.690 |
Why?
|
Cyclic AMP Response Element Modulator | 4 | 2022 | 25 | 0.690 |
Why?
|
Proteostasis | 1 | 2020 | 34 | 0.680 |
Why?
|
Behcet Syndrome | 1 | 2019 | 16 | 0.650 |
Why?
|
Calcium-Binding Proteins | 6 | 2019 | 327 | 0.650 |
Why?
|
Disease Models, Animal | 21 | 2022 | 4289 | 0.640 |
Why?
|
Isoproterenol | 5 | 2022 | 105 | 0.620 |
Why?
|
Heart Conduction System | 4 | 2024 | 145 | 0.610 |
Why?
|
Gastrointestinal Microbiome | 2 | 2022 | 680 | 0.580 |
Why?
|
Inflammation | 3 | 2022 | 1403 | 0.570 |
Why?
|
Tetracaine | 1 | 2016 | 9 | 0.550 |
Why?
|
Down-Regulation | 7 | 2023 | 697 | 0.540 |
Why?
|
Hyperuricemia | 1 | 2016 | 36 | 0.530 |
Why?
|
Uric Acid | 1 | 2016 | 93 | 0.520 |
Why?
|
Channelopathies | 1 | 2016 | 11 | 0.520 |
Why?
|
Humans | 50 | 2025 | 123305 | 0.510 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 716 | 0.490 |
Why?
|
Myocardial Infarction | 2 | 2019 | 1003 | 0.480 |
Why?
|
Epigenomics | 1 | 2015 | 161 | 0.470 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 1638 | 0.470 |
Why?
|
Receptors, Adrenergic, beta | 2 | 2015 | 58 | 0.470 |
Why?
|
Mice, Knockout | 16 | 2021 | 3722 | 0.470 |
Why?
|
Action Potentials | 7 | 2021 | 501 | 0.470 |
Why?
|
Patch-Clamp Techniques | 9 | 2018 | 277 | 0.460 |
Why?
|
Gene Expression Regulation | 6 | 2013 | 2524 | 0.460 |
Why?
|
Biomarkers | 5 | 2024 | 2948 | 0.450 |
Why?
|
Pyrazoles | 4 | 2010 | 305 | 0.450 |
Why?
|
Mice, Transgenic | 12 | 2022 | 2396 | 0.450 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 6 | 2018 | 37 | 0.430 |
Why?
|
Electric Stimulation | 2 | 2012 | 318 | 0.420 |
Why?
|
Physical Endurance | 1 | 2013 | 46 | 0.420 |
Why?
|
Propanolamines | 1 | 2012 | 31 | 0.410 |
Why?
|
Carbazoles | 1 | 2012 | 32 | 0.410 |
Why?
|
Morpholines | 1 | 2012 | 56 | 0.400 |
Why?
|
Long QT Syndrome | 2 | 2012 | 85 | 0.400 |
Why?
|
RNA, Messenger | 4 | 2022 | 2813 | 0.400 |
Why?
|
Endothelin Receptor Antagonists | 2 | 2010 | 14 | 0.400 |
Why?
|
Physical Conditioning, Animal | 1 | 2013 | 91 | 0.390 |
Why?
|
Exercise Test | 1 | 2013 | 249 | 0.390 |
Why?
|
Obesity | 3 | 2023 | 2233 | 0.380 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2024 | 190 | 0.370 |
Why?
|
Death, Sudden, Cardiac | 2 | 2010 | 248 | 0.360 |
Why?
|
Endothelins | 1 | 2010 | 8 | 0.350 |
Why?
|
Receptor, Endothelin A | 3 | 2008 | 12 | 0.350 |
Why?
|
Homeodomain Proteins | 3 | 2019 | 544 | 0.330 |
Why?
|
Potassium Channels | 1 | 2010 | 158 | 0.320 |
Why?
|
Phosphorylation | 11 | 2020 | 1610 | 0.320 |
Why?
|
Vitamin E | 1 | 2008 | 64 | 0.300 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2007 | 47 | 0.290 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 4357 | 0.290 |
Why?
|
Mutation | 9 | 2024 | 5768 | 0.290 |
Why?
|
Rats | 11 | 2015 | 3664 | 0.290 |
Why?
|
Cells, Cultured | 8 | 2020 | 3043 | 0.280 |
Why?
|
Hypertension, Pulmonary | 2 | 2008 | 434 | 0.270 |
Why?
|
Ion Channels | 1 | 2007 | 188 | 0.270 |
Why?
|
Cardiomyopathies | 3 | 2022 | 478 | 0.260 |
Why?
|
Male | 26 | 2025 | 60282 | 0.260 |
Why?
|
Reactive Oxygen Species | 4 | 2025 | 481 | 0.260 |
Why?
|
Sodium-Calcium Exchanger | 3 | 2016 | 21 | 0.260 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 350 | 0.250 |
Why?
|
Hypoxia | 2 | 2023 | 248 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 3081 | 0.250 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 2055 | 0.250 |
Why?
|
Interleukin-1beta | 2 | 2023 | 159 | 0.250 |
Why?
|
Pyroptosis | 1 | 2025 | 22 | 0.240 |
Why?
|
Muscular Dystrophy, Duchenne | 2 | 2018 | 63 | 0.240 |
Why?
|
Membrane Potentials | 5 | 2013 | 304 | 0.240 |
Why?
|
Cardiac Conduction System Disease | 1 | 2024 | 7 | 0.230 |
Why?
|
Case-Control Studies | 4 | 2021 | 3240 | 0.230 |
Why?
|
Aged | 11 | 2024 | 19173 | 0.230 |
Why?
|
NFATC Transcription Factors | 2 | 2022 | 42 | 0.230 |
Why?
|
Dioxygenases | 1 | 2024 | 46 | 0.220 |
Why?
|
Gene Knock-In Techniques | 4 | 2019 | 122 | 0.220 |
Why?
|
Glucosides | 1 | 2024 | 46 | 0.220 |
Why?
|
Receptors, Interleukin-6 | 1 | 2023 | 38 | 0.220 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 67 | 0.210 |
Why?
|
Fibrosis | 3 | 2022 | 429 | 0.210 |
Why?
|
Cytoplasm | 1 | 2024 | 289 | 0.210 |
Why?
|
Transcription Factors | 3 | 2019 | 2587 | 0.200 |
Why?
|
Heart Ventricles | 2 | 2018 | 763 | 0.200 |
Why?
|
Rats, Sprague-Dawley | 7 | 2010 | 1217 | 0.200 |
Why?
|
Heat-Shock Proteins | 1 | 2023 | 194 | 0.200 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 1877 | 0.190 |
Why?
|
Calmodulin | 3 | 2017 | 230 | 0.190 |
Why?
|
Folic Acid | 1 | 2024 | 292 | 0.190 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 352 | 0.190 |
Why?
|
Adiposity | 1 | 2023 | 191 | 0.190 |
Why?
|
Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.190 |
Why?
|
Sheep, Domestic | 1 | 2021 | 17 | 0.190 |
Why?
|
Ataxia | 1 | 2022 | 168 | 0.180 |
Why?
|
Ankyrins | 2 | 2012 | 99 | 0.180 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 548 | 0.180 |
Why?
|
Dependovirus | 2 | 2019 | 130 | 0.180 |
Why?
|
Guinea Pigs | 3 | 2010 | 167 | 0.180 |
Why?
|
DNA | 2 | 2017 | 1594 | 0.170 |
Why?
|
Receptors, Thrombin | 1 | 2020 | 11 | 0.170 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2020 | 15 | 0.170 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2019 | 7 | 0.170 |
Why?
|
Silk | 1 | 2019 | 3 | 0.170 |
Why?
|
Up-Regulation | 4 | 2019 | 861 | 0.160 |
Why?
|
Genetic Loci | 1 | 2021 | 332 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 528 | 0.160 |
Why?
|
Repressor Proteins | 1 | 2024 | 816 | 0.160 |
Why?
|
CRISPR-Cas Systems | 2 | 2019 | 257 | 0.160 |
Why?
|
Natriuretic Peptide, C-Type | 1 | 2019 | 13 | 0.160 |
Why?
|
Female | 20 | 2024 | 65618 | 0.160 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 1339 | 0.160 |
Why?
|
Endothelin B Receptor Antagonists | 2 | 2008 | 4 | 0.160 |
Why?
|
Endothelin A Receptor Antagonists | 2 | 2008 | 9 | 0.160 |
Why?
|
Sorting Nexins | 1 | 2018 | 10 | 0.160 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2019 | 114 | 0.150 |
Why?
|
Protein Phosphatase 1 | 2 | 2019 | 50 | 0.150 |
Why?
|
Oxides | 1 | 2018 | 15 | 0.150 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 643 | 0.150 |
Why?
|
Methylamines | 1 | 2018 | 17 | 0.150 |
Why?
|
Sodium | 1 | 2019 | 294 | 0.150 |
Why?
|
Protein Precursors | 1 | 2019 | 149 | 0.150 |
Why?
|
Hypertension | 2 | 2021 | 1286 | 0.150 |
Why?
|
Genetic Vectors | 2 | 2019 | 941 | 0.150 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 298 | 0.150 |
Why?
|
Exercise | 1 | 2024 | 816 | 0.150 |
Why?
|
Heart Arrest | 1 | 2022 | 342 | 0.150 |
Why?
|
Risk Factors | 4 | 2021 | 10042 | 0.140 |
Why?
|
Seizures | 1 | 2022 | 874 | 0.140 |
Why?
|
Neutrophils | 1 | 2019 | 373 | 0.140 |
Why?
|
3' Untranslated Regions | 2 | 2014 | 165 | 0.140 |
Why?
|
Gene Transfer Techniques | 1 | 2019 | 357 | 0.140 |
Why?
|
Thiazepines | 1 | 2016 | 8 | 0.140 |
Why?
|
Antioxidants | 2 | 2010 | 338 | 0.130 |
Why?
|
Aging | 2 | 2022 | 1183 | 0.130 |
Why?
|
Gene Editing | 1 | 2018 | 190 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1290 | 0.130 |
Why?
|
Anesthetics, Local | 1 | 2016 | 80 | 0.130 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 110 | 0.130 |
Why?
|
Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2015 | 23 | 0.120 |
Why?
|
Kv1.1 Potassium Channel | 1 | 2015 | 37 | 0.120 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2015 | 35 | 0.120 |
Why?
|
Potassium | 1 | 2016 | 280 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 1686 | 0.120 |
Why?
|
Sulfonamides | 3 | 2018 | 259 | 0.120 |
Why?
|
Protein Conformation | 1 | 2016 | 833 | 0.110 |
Why?
|
Microarray Analysis | 1 | 2015 | 231 | 0.110 |
Why?
|
Genetic Therapy | 1 | 2018 | 679 | 0.110 |
Why?
|
Blotting, Western | 3 | 2012 | 1101 | 0.110 |
Why?
|
COUP Transcription Factor I | 1 | 2013 | 91 | 0.110 |
Why?
|
Ear, Inner | 1 | 2013 | 52 | 0.110 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2013 | 12 | 0.110 |
Why?
|
Cardiomegaly | 2 | 2012 | 133 | 0.100 |
Why?
|
Apoptosis | 1 | 2019 | 1787 | 0.100 |
Why?
|
Cytokines | 1 | 2018 | 1284 | 0.100 |
Why?
|
Disease Progression | 3 | 2014 | 2031 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2013 | 92 | 0.100 |
Why?
|
NADPH Oxidases | 2 | 2013 | 114 | 0.100 |
Why?
|
Ventricular Fibrillation | 1 | 2012 | 51 | 0.100 |
Why?
|
Electrocardiography | 4 | 2010 | 958 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 1 | 2020 | 1099 | 0.100 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 850 | 0.090 |
Why?
|
Ventricular Remodeling | 2 | 2012 | 174 | 0.090 |
Why?
|
Middle Aged | 8 | 2024 | 26075 | 0.090 |
Why?
|
Protein Subunits | 1 | 2011 | 164 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 351 | 0.090 |
Why?
|
Time Factors | 4 | 2014 | 6228 | 0.090 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2008 | 137 | 0.090 |
Why?
|
Calcium Channels | 1 | 2011 | 159 | 0.090 |
Why?
|
Calcium Channel Blockers | 2 | 2008 | 113 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2019 | 1523 | 0.090 |
Why?
|
Mice, Inbred mdx | 3 | 2018 | 40 | 0.090 |
Why?
|
Molecular Structure | 2 | 2007 | 284 | 0.090 |
Why?
|
Models, Animal | 1 | 2011 | 464 | 0.080 |
Why?
|
Sudden Infant Death | 1 | 2009 | 33 | 0.080 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 160 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2014 | 1702 | 0.080 |
Why?
|
Cornus | 1 | 2008 | 1 | 0.080 |
Why?
|
Triterpenes | 1 | 2008 | 21 | 0.080 |
Why?
|
Oxidation-Reduction | 3 | 2018 | 444 | 0.080 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2008 | 10 | 0.080 |
Why?
|
Matrix Metalloproteinase Inhibitors | 1 | 2008 | 18 | 0.080 |
Why?
|
Guanidines | 1 | 2008 | 25 | 0.080 |
Why?
|
Biomarkers, Pharmacological | 1 | 2008 | 10 | 0.080 |
Why?
|
Protein Kinase C-epsilon | 1 | 2008 | 13 | 0.080 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 37 | 0.080 |
Why?
|
Stereoisomerism | 1 | 2008 | 103 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 1679 | 0.070 |
Why?
|
Phenethylamines | 1 | 2007 | 14 | 0.070 |
Why?
|
Torsades de Pointes | 1 | 2007 | 6 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2007 | 104 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 664 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2008 | 196 | 0.070 |
Why?
|
Age Factors | 1 | 2014 | 2805 | 0.070 |
Why?
|
Naphthalenes | 1 | 2007 | 37 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2008 | 232 | 0.070 |
Why?
|
Proteomics | 2 | 2021 | 479 | 0.070 |
Why?
|
Oxidative Stress | 4 | 2018 | 795 | 0.070 |
Why?
|
Myocardial Contraction | 3 | 2015 | 260 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2017 | 382 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2010 | 556 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2008 | 439 | 0.060 |
Why?
|
Aorta | 1 | 2007 | 542 | 0.060 |
Why?
|
United Kingdom | 1 | 2024 | 190 | 0.060 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 790 | 0.050 |
Why?
|
Aorta, Thoracic | 1 | 2008 | 520 | 0.050 |
Why?
|
Immunoblotting | 2 | 2015 | 313 | 0.050 |
Why?
|
Echocardiography | 2 | 2024 | 1049 | 0.050 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2022 | 4 | 0.050 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 129 | 0.050 |
Why?
|
Pericardium | 1 | 2023 | 82 | 0.050 |
Why?
|
Troponin T | 1 | 2024 | 245 | 0.050 |
Why?
|
Verapamil | 1 | 2022 | 52 | 0.050 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2022 | 58 | 0.050 |
Why?
|
Magnesium | 1 | 2022 | 121 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2024 | 406 | 0.050 |
Why?
|
Rabbits | 2 | 2016 | 709 | 0.050 |
Why?
|
Lung | 1 | 2008 | 1466 | 0.050 |
Why?
|
Treatment Outcome | 1 | 2016 | 12168 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2022 | 399 | 0.040 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 332 | 0.040 |
Why?
|
Child | 4 | 2024 | 24264 | 0.040 |
Why?
|
Dysbiosis | 1 | 2021 | 118 | 0.040 |
Why?
|
Phenotype | 3 | 2018 | 4226 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2023 | 464 | 0.040 |
Why?
|
Caspase 1 | 1 | 2020 | 41 | 0.040 |
Why?
|
Prenatal Care | 1 | 2022 | 346 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 467 | 0.040 |
Why?
|
Indenes | 1 | 2018 | 10 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2015 | 1688 | 0.040 |
Why?
|
Atrial Natriuretic Factor | 1 | 2019 | 52 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2020 | 233 | 0.040 |
Why?
|
Receptor, Endothelin B | 2 | 2008 | 6 | 0.040 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 25 | 0.040 |
Why?
|
Furans | 1 | 2018 | 27 | 0.040 |
Why?
|
Sulfones | 1 | 2018 | 66 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2009 | 115 | 0.040 |
Why?
|
Hypertrophy | 1 | 2018 | 101 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2019 | 157 | 0.040 |
Why?
|
Homeostasis | 1 | 2022 | 683 | 0.040 |
Why?
|
NADPH Oxidase 2 | 1 | 2018 | 40 | 0.040 |
Why?
|
Diet, High-Fat | 1 | 2020 | 211 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2019 | 384 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2019 | 298 | 0.040 |
Why?
|
Dogs | 1 | 2018 | 765 | 0.040 |
Why?
|
Arteries | 1 | 2018 | 222 | 0.040 |
Why?
|
Sheep | 1 | 2017 | 208 | 0.040 |
Why?
|
RNA Interference | 1 | 2018 | 496 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2019 | 1082 | 0.030 |
Why?
|
Dantrolene | 1 | 2016 | 6 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 664 | 0.030 |
Why?
|
Permeability | 1 | 2016 | 118 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2019 | 416 | 0.030 |
Why?
|
Ion Channel Gating | 1 | 2016 | 123 | 0.030 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
Hydroxylation | 1 | 2015 | 45 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2022 | 2307 | 0.030 |
Why?
|
Fibroblasts | 1 | 2020 | 881 | 0.030 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 37 | 0.030 |
Why?
|
Cell Line | 1 | 2020 | 2771 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 98 | 0.030 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2013 | 3 | 0.030 |
Why?
|
Electroencephalography | 1 | 2018 | 857 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2014 | 112 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2013 | 69 | 0.030 |
Why?
|
Prospective Studies | 1 | 2024 | 6032 | 0.030 |
Why?
|
Atrial Appendage | 1 | 2013 | 43 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2014 | 121 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2015 | 510 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2015 | 258 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 110 | 0.030 |
Why?
|
Muscle Cells | 1 | 2012 | 24 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 393 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2013 | 180 | 0.030 |
Why?
|
Angiotensin II | 1 | 2013 | 161 | 0.030 |
Why?
|
Benzylamines | 1 | 2012 | 16 | 0.030 |
Why?
|
Infant | 2 | 2022 | 12379 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 2012 | 87 | 0.020 |
Why?
|
Lipid Bilayers | 1 | 2012 | 46 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2014 | 275 | 0.020 |
Why?
|
Ventricular Pressure | 1 | 2012 | 43 | 0.020 |
Why?
|
Protein Binding | 1 | 2016 | 1741 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 428 | 0.020 |
Why?
|
Caffeine | 1 | 2012 | 71 | 0.020 |
Why?
|
Serine | 1 | 2012 | 172 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2011 | 154 | 0.020 |
Why?
|
Computer Simulation | 1 | 2013 | 630 | 0.020 |
Why?
|
Sarcolemma | 1 | 2010 | 24 | 0.020 |
Why?
|
Phosphoserine | 1 | 2010 | 41 | 0.020 |
Why?
|
Intracellular Space | 1 | 2010 | 48 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2012 | 214 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 369 | 0.020 |
Why?
|
Death, Sudden | 1 | 2010 | 45 | 0.020 |
Why?
|
Voltage-Sensitive Dye Imaging | 1 | 2009 | 7 | 0.020 |
Why?
|
Theophylline | 1 | 2009 | 29 | 0.020 |
Why?
|
Adrenergic Agonists | 1 | 2009 | 11 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 356 | 0.020 |
Why?
|
Pregnancy | 1 | 2022 | 7156 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 81 | 0.020 |
Why?
|
Goats | 1 | 2009 | 55 | 0.020 |
Why?
|
Calcineurin | 1 | 2010 | 100 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2012 | 767 | 0.020 |
Why?
|
Streptozocin | 1 | 2008 | 24 | 0.020 |
Why?
|
Monocrotaline | 1 | 2008 | 3 | 0.020 |
Why?
|
Arterioles | 1 | 2008 | 28 | 0.020 |
Why?
|
Endothelin-1 | 1 | 2008 | 39 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 660 | 0.020 |
Why?
|
Nifedipine | 1 | 2008 | 21 | 0.020 |
Why?
|
Epinephrine | 1 | 2009 | 175 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2012 | 496 | 0.020 |
Why?
|
Muscle Relaxation | 1 | 2008 | 16 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2008 | 94 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 1112 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 524 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2008 | 135 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2008 | 186 | 0.020 |
Why?
|
Chronic Disease | 1 | 2012 | 1166 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 2014 | 0.020 |
Why?
|
Methoxamine | 1 | 2007 | 2 | 0.020 |
Why?
|
Refractory Period, Electrophysiological | 1 | 2007 | 9 | 0.020 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2007 | 34 | 0.020 |
Why?
|
Child, Preschool | 1 | 2022 | 13916 | 0.020 |
Why?
|
Calcium Channels, L-Type | 1 | 2007 | 53 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 2695 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 239 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2008 | 967 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 3867 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2009 | 992 | 0.020 |
Why?
|
Peptides | 1 | 2009 | 793 | 0.020 |
Why?
|
Base Sequence | 1 | 2010 | 3091 | 0.020 |
Why?
|
Adolescent | 1 | 2022 | 19132 | 0.010 |
Why?
|
Adult | 2 | 2012 | 29087 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 3547 | 0.010 |
Why?
|
Algorithms | 1 | 2007 | 1599 | 0.010 |
Why?
|
Young Adult | 1 | 2011 | 8871 | 0.010 |
Why?
|